One step closer to a longevity drug: LOY-002 hits key FDA milestone. Read more →
We’re helping dogs like yours live longer and stay healthier as they age.
Our products focus on preventive care, addressing the underlying causes of a range of age‑associated diseases to delay their onset and reduce their impact.
Correcting overexpression of IGF-1 and growth hormone (GH) in large dogs post-maturity
We’ve completed two of three major requirements for conditional approval.Our senior dog longevity drug, LOY-002, has completed its safety package (TAS) for conditional approval - a crucial step towards bringing the first FDA-approved longevity drug to dog owners and veterinarians.
Meet Boo — the first dog dosed in our LOY-002 pivotal study for extending healthy lifespan in dogs of nearly all sizes Announcing our partnership with Crinetics Pharmaceuticals Loyal’s latest milestone: the first longevity clinical study design supported by the FDA
Contact vendor for pricing
Share your experience to help healthcare professionals make better decisions.
+2 more
+4 more
+2 more
+2 more